Skip to main content
Equibles

CITIGROUP INC

Position in TVGN — Tevogen Inc.

CIK 831001 NEW YORK, NY
Back to TVGN Full portfolio

Position in TVGN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$345
+$151 QoQ
Shares Held
61
+41.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 29 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVGN Over Time

Shares Held

Position Value (USD)

Derivatives in TVGN

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
77,151
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. TVGN ranks #359 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 706,968 $351,172,214
2 REGN
Regeneron Pharmaceuticals, Inc.
 346,637 $216,142,034
3 MRNA
Moderna, Inc.
 2,165,414 $151,643,941
4 ROIV
Roivant Sciences Ltd.
 2,225,190 $78,749,472
5 ALNY
Alnylam Pharmaceuticals, Inc.
 227,786 $68,570,419
6 INCY
Incyte Corp
 586,431 $66,477,817
7 BBIO
BridgeBio Pharma, Inc.
 864,101 $64,358,241
8 RVMD
Revolution Medicines, Inc.
 247,052 $46,267,897

All Filings in TVGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $345 61
2026-03-31 $194 43
2025-12-31 $308 931
2025-09-30 $3,646 4,645
2025-06-30 $16,655 13,325
2025-03-31 $20,466 18,951
2024-12-31 $18,451 17,915
2024-09-30 $5,981 16,253
2024-06-30 $3,489 4,826